
Results
3
Companies which are more than 50% undervalued based on analyst price target.
3 companies
UBM Development
Market Cap: €138.7m
Engages in the development, management, and sale of real estate properties in Germany, Austria, Poland, and internationally.
UBS
€18.80
7D
-2.8%
1Y
-2.1%
Marinomed Biotech
Market Cap: €31.3m
A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.
MARI
€17.10
7D
-2.0%
1Y
22.6%
Warimpex Finanz- und Beteiligungs
Market Cap: €25.4m
Operates as a real estate development and investment company in Austria, Germany, Hungary, Russia, and Poland.
WXF
€0.49
7D
1.7%
1Y
-27.1%